• Accueil >
  • Publications >
  • Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers

Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers

1 nov. 2019Gynecologic Oncology

DOI : 10.1016/j.ygyno.2019.09.008

Auteurs

S. Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, Anita Wolfer, Elsa Kalbacher, Timothée Olivier, Jean-Damien Combes, Ketty Heimgartner-Hu, Olivier Tredan, Hemerson Guevara, Pierre-Etienne Heudel, Thibaut Reverdy, Fernando Bazan, Viola Heinzelmann-Schwarz, Mathias Fehr, Victoire de Castelbajac, Pauline Vaflard, Louise Crivelli, Valerie Bonadona, Valeria Viassolo, Adrien Buisson, Lisa Golmard, Manuel Rodrigues, Isabelle Ray-Coquard